18:45:53 EDT Wed 23 May 2018
Enter Symbol
or Name
USA
CA



Q:AMBS - AMARANTUS BIOSCIEN - http://www.amarantus.com18:45:53 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AMBS - Qnot subscribed0.052+0.00613.0912.942520.054  0.054  0.0420.2085  0.0115:55:0211:3015 min RT 2¢

Recent Trades - Last 10 of 52
Time ETExPriceChangeVolume
15:55:02Q0.0520.0061,000
15:27:43Q0.04620.000218,000
15:27:43Q0.04620.000221,498
15:27:29Q0.04242-0.00358131,600
15:27:29Q0.0465970.0005979,900
15:26:08Q0.04242-0.0035828,400
15:20:15Q0.04910.0031500
15:20:14Q0.04630.0003500
15:14:12Q0.05090.0049500
15:13:42Q0.04620.00021,784

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2018-05-23 11:30U:AMBSNews ReleaseSeeThruEquity Issues Update on Amarantus Bioscience Holdings, Inc.
2018-05-22 06:00U:AMBSNews ReleaseAmarantus Retains Weild & Co. to Advise on JOBS Act Funding
2018-05-21 08:41U:AMBSNews ReleaseMANF Therapeutics Announces Publication in Society for Neuroscience eNeuro Journal of Human Ocular Distribution and Animal Photoreceptor Protection Data for MANF
2018-05-11 10:25U:AMBSNews ReleaseAmarantus Provides Business Overview
2018-05-04 08:45U:AMBSNews ReleaseAmarantus Enters into Exclusive Option Agreement with Leipzig University to License IP Covering Alzheimer's Blood Diagnostic LymPro Test 2.0 Blood Test vs. Amyloid PET
2018-05-03 09:15U:AMBSNews ReleaseMANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's
2018-05-01 10:32U:AMBSNews ReleaseElto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairment
2018-04-30 07:00U:AMBSNews ReleaseElto PharmaAppoints Paula Trzepacz, MD asChief Medical Advisor